Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51
- 1 August 2006
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 65 (5) , 1429-1439
- https://doi.org/10.1016/j.ijrobp.2006.03.061
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962Journal of Clinical Oncology, 2003
- Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred RadiotherapyJournal of Clinical Oncology, 2003
- Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07Journal of Clinical Oncology, 2003
- Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma: Radiation Therapy Oncology Group Study 93-10Journal of Clinical Oncology, 2002
- The continuing increase in the incidence of primary central nervous system non‐Hodgkin lymphomaCancer, 2002
- Treatment for Primary CNS Lymphoma: The Next StepJournal of Clinical Oncology, 2000
- Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS LymphomaJournal of Clinical Oncology, 2000
- The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: Cognitive function and performance statusNeuro-Oncology, 1999
- Primary central nervous system non-hodgkin’s lymphoma (PCNSL): survival advantages with combined initial therapy? a final report of the north central cancer treatment group (NCCTG) study 86-72-52International Journal of Radiation Oncology*Biology*Physics, 1999
- Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?International Journal of Radiation Oncology*Biology*Physics, 1995